A61P 9 - Drugs for disorders of the cardiovascular system

Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
10/2011
10/20/2011	US20110257126 Water soluble curcumin compositions for use in anti-cancer and anti-inflammatory therapy
10/20/2011	US20110257119 Microcirculation improvement and/or treatment
10/20/2011	US20110257118 Vascular Circulation in Peripheral and/or Small Blood Vessels
10/20/2011	US20110257117 Olive compositions and methods for treating inflammatory conditions
10/20/2011	US20110257110 Composition comprising a glycoside of a mono- or diacylglycerol compound and an oil rich in n-3 polyunsaturated fatty acids, a method of producing the composition and use of the composition
10/20/2011	US20110257099 Use of Natriuretic Peptide for Treating Heart Failure
10/20/2011	US20110257095 Pharmaceutical compositions and related methods of delivery
10/20/2011	US20110257085 Crystal Forms of Saxagliptin and Processes for Preparing Same
10/20/2011	US20110256229 Rapid-acting pharmaceutical composition
10/20/2011	US20110256224 Methods and compositions for targeted delivery
10/20/2011	US20110256222 Recombinant Protein Enriched in a Heparin Binding Site and/or in a Heparan Sulfate Binding Site
10/20/2011	US20110256220 Pharmaceutical compositions of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid and administration thereof
10/20/2011	US20110256186 biomaterial based on wharton's jelly from the human umbilical cord
10/20/2011	US20110256160 Adherent cells from placenta tissue and use thereof in therapy
10/20/2011	US20110256159 Adherent cells from placenta tissue and use thereof in therapy
10/20/2011	US20110256156 TRANSFERRIN/TRANSFERRIN RECEPTOR-MEDIATED siRNA DELIVERY
10/20/2011	US20110256139 Therapeutic Uses Of Monoclonal Antibodies To The Angiotensin-II Type 1 Receptor
10/20/2011	US20110256134 Methods of treatment using anti-oxidized ldl antibodies
10/20/2011	US20110256132 Myostatin binding proteins
10/20/2011	US20110256130 Methods of treating inflammatory disorders
10/20/2011	US20110256121 Methods and kits for diagnosing or monitoring autoimmune and chronic inflammatory diseases
10/20/2011	US20110256115 Hydrosoluble [6)o-alpha-d-glcp-(1->]n-6-o-beta-d-glcp-(1->-phenolic derivatives with dermocosmetic, nutritional and therapeutic applications, and compositions containing said water soluble compounds
10/20/2011	US20110256112 Compensating for Atrioventricular Block Using a Nucleic Acid Encoding a Sodium Channel or Gap Junction Protein
10/20/2011	US20110256108 Methods of selection of cells for transplantation
10/20/2011	US20110256105 Cardiac stem cell and myocyte secreted paracrine factors
10/20/2011	US20110256104 Complexing agents for compositions containing inclusion complexes
10/20/2011	US20110256097 Treatment of Conditions that Increase in Severity and/or Occurrence During One or More Phases of the Menstrual Cycle
10/20/2011	US20110256093 Treating Disorders Associated with IL-20 Receptor-Mediated Signaling Pathway by Blocking IL-20 Receptor Activity
10/20/2011	CA2795720A1 Pharmaceutical composition for treating macular edema
10/20/2011	CA2790687A1 Aryl - /heteroaryl - cyclohexenyl - tetraazabenzo [e] azulenes as vasopressin antagonists
10/19/2011	EP2377875A1 Antioxidant
10/19/2011	EP2377874A1 Antioxidant
10/19/2011	EP2377865A1 Cyclobutyl purine derivative, angiogenesis promoting agent, lumenization promoting agent, neurocyte growth promoting agent, and drug
10/19/2011	EP2377855A1 A valsartanamide dinitrate derivative for the treatment of vascular and metabolic diseases
10/19/2011	EP2377544A2 Pharmaceutical composition containing angiotensin-(1-9) for cardiovascular, pulmonary and/or cerebral treatment
10/19/2011	EP2377534A1 Methods of treating alpha adrenergic mediated conditions
10/19/2011	EP2377529A1 Use of racemates of pinocembrin in preparing medicaments for treating stroke
10/19/2011	EP2376502A1 Thiazolopyridine sirtuin modulating compounds
10/19/2011	EP2376490A1 Imidazopyridine compounds
10/19/2011	EP2376473A1 3,4 - substituted piperidine derivatives as renin inhibitors
10/19/2011	EP2376462A1 Thiazoles as cannabinoid receptor ligands
10/19/2011	EP2376432A1 Novel eicosanoid derivatives
10/19/2011	EP2376425A2 Kinase inhibitor compounds
10/19/2011	EP2376101A2 ß-ARRESTIN EFFECTORS AND COMPOSITIONS AND METHODS OF USE THEREOF
10/19/2011	EP2376065A2 Solid composition for controlled release of ionizable active agents with poor aqueous solubility at low ph and methods of use thereof
10/19/2011	EP2375899A1 Piperidine-containing compounds and use thereof
10/19/2011	EP2363142A9 Elastase for opening obstructed biological conduits
10/19/2011	EP2221377B1 Oligonucleotide compositions with enhanced efficiency
10/19/2011	EP1762610B1 Truncated dance, dance complex and method of using these
10/19/2011	EP1736206B1 Physiologically active composition and process for producing the same
10/19/2011	EP1494671B1 1-(4-piperidinyl)benzimidazolones as histamine h3 antagonists
10/19/2011	EP1482931B1 Mono- and bicyclic azole derivatives that inhibit the interaction of ligands with rage
10/19/2011	EP1372735B1 Conjugate of hydroxyalkyl starch and an active agent
10/19/2011	EP1173197B2 Metabolic intervention with glp-1 to improve the function of ischemic and reperfused tissue
10/19/2011	EP1041982B1 INHIBITION OF p38 KINASE ACTIVITY USING SUBSTITUTED HETEROCYCLIC UREAS
10/19/2011	CN202010289U Combined capsule containing hydrochlorothiazide solid formulation and aliskiren solid formulation
10/19/2011	CN102224142A Novel pyrazole-3-carboxamide derivative having 5-ht2b receptor antagonist activity
10/19/2011	CN102224138A Indole derivatives, method for preparing same and pharmaceutical compositions containing same
10/19/2011	CN102223892A Compounds and methods for the treatment of vascular disease
10/19/2011	CN102223884A Solid pharmaceutical composition
10/19/2011	CN102223882A Phosphodiesterase type iii (pde iii) inhibitors or ca2+-sensitizing agents for the treatment of hypertrophic cardiomyopathy
10/19/2011	CN102219850A New long-acting GLP-1 (glucagonlike peptide-1) compounds
10/19/2011	CN102219748A Amorphous Ambrisentan and preparation method thereof
10/19/2011	CN102219741A Process for preparing benzazepine compounds or salts thereof
10/19/2011	CN102219740A 1,2,3,4,5,6,7,8-octahydro-9-phenylacetamide acridine as well as preparation method and medicinal application thereof
10/19/2011	CN102218144A Method for regulating content of micro-ribonucleic acids in organism and use thereof
10/19/2011	CN102218134A L-arginine-glucose-insulin-potassium chloride composition and application thereof
10/19/2011	CN102218132A Medicinal composition for treating nasal bleeding
10/19/2011	CN102218095A Processing method of myrobalan-processed kusnezoff monkshood root as mongolian medicine
10/19/2011	CN102218090A Rice roasting processing method of traditional Chinese medicine salvia miltiorrhiza bunge
10/19/2011	CN102218087A Method for preparing total flavone extracts of pagoda flower
10/19/2011	CN102218086A Traditional Chinese medicine ointment for treating hemorrhoids
10/19/2011	CN102218085A Quality control method for leaves of lithocarpus litseifolius(Hance)Chun as medicinal material
10/19/2011	CN102218077A Use of poloxamer for the prevention and/or treatment of heart failure
10/19/2011	CN102218067A Use of oxicam compounds
10/19/2011	CN102218058A Application of sparstolenin B as TLR2 (Toll-like receptor 2)/TLR4 (Toll-like receptor 4) antagonist in pharmacy
10/19/2011	CN102218054A Use of apigenin in preparing drugs for preventing and/or treating cardiovascular and cerebrovascular diseases
10/19/2011	CN102218053A Application of luteolin in preparation of medicaments for inhibiting angiogenesis
10/19/2011	CN102218049A Anti-ageing medicine or health care food composition and application
10/19/2011	CN102218043A LDH (Layered Double Hydroxides) supermolecular assembly type aspirin sustained release tablet and preparation method thereof
10/19/2011	CN102218038A Formula, preparation method and application of tolazoline hydrochloride liposome combination medicine
10/19/2011	CN102218033A Formula, preparation method and use of alprostadil liposome combined medicament
10/19/2011	CN102217980A Preparation method for rhesus monkey choroids angiogenesis models
10/19/2011	CN102217882A Chinese medicinal pillow for preventing high blood pressure
10/19/2011	CN102217757A Plant superoxide dismutase buccal tablets and preparation method thereof
10/19/2011	CN102028662B Levamlodipine besylate tablet, preparation process thereof and control method for relevant materials
10/19/2011	CN101904819B Method for preparing taurine particles
10/19/2011	CN101785782B Long-circulating ligustrazine composite injection and preparation method thereof
10/19/2011	CN101693718B Ester derivative containing thienopyridine and preparation method and application thereof
10/19/2011	CN101657208B A chinese medicine composition and the extract of worms thereof and their preparation
10/19/2011	CN101573300B Hydrogen-dissolved aqueous solution and method for prolonging the life duration of hydrogen dissolved in the aqueous solution
10/19/2011	CN101474150B Stable alprostadil injection emulsion and preparation method thereof
10/19/2011	CN101439075B Medicament for increasing high density lipoprotein, preventing and treating atherosclerosis, and preparation method thereof
10/19/2011	CN101269142B Application of Chinese medicinal composition in preparing medicament for treating right bundle branch conduction block
10/19/2011	CN101268073B Heterocyclic compound, and production process and use thereof
10/19/2011	CN101228126B Process for the preparation of crystalline perindopril
10/19/2011	CN101204372B Cinepazide maleate injection and preparation method thereof
10/19/2011	CN101152147B Ligustrazine compound emulsion and method for preparing the same
10/18/2011	US8039647 2-amino-bicyclo (3.1.0) hexane-2,6-dicarboxylic ester derivative
10/18/2011	US8039488 Methods and compositions for inhibition of angiogenesis

1 ... 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 ... 1595